| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8528317 | Clinical Therapeutics | 2017 | 10 Pages |
Abstract
The clinically relevant differences observed between the 2 patient populations suggest that GLP-1-RAs and basal insulin are prescribed to different types of patients with T2DM. Examining patients' demographic and clinical characteristics may be important in assisting physicians in the choice of patient-centered injectable treatment regimens.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Maria MS, Reema PhD, Laura Fernández MD, Amy MS, Lee PhD, MPH, Lukas MPH, Carolina Piras MD,